Our comprehensive pharmaceutical development service offering includes new drug development, early stage formulation and analytical development for both highly potent and non-potent drug products.

PCI provides a comprehensive service at each stage of the product lifecycle for a wide range of dosage forms, in full compliance with GMP regulatory standards for both highly potent and non-potent drug products.

PCI offers flexible and globally compliant commercial scale manufacturing and packaging of multiple dosage forms including tablets, capsules, creams, gels, ointments and oral liquids for both highly potent and non-potent drug products.

Our specialized high potent manufacturing expertise is built on 35 years experience in potent processing and offers a purpose-built facility utilizing the very latest in containment technology. This enables the safe development and clinical and commercial supply of products with an occupational exposure limit (OEL) as low as 0.01µg/m³.

Roller compaction is a proven process providing a method of granulation for materials that are known to be sensitive to heat and/or moisture.

PCI offers in-house laboratories providing a range of analytical services to support clients in the development, clinical and commercial supply of medicines globally.

Qualified Persons (QPs) deliver a vital role in bringing new products to market. Our highly experienced team assumes responsibility for all stages of the product lifecycle, ultimately safeguarding patients.

With over 80 serialization lines across our global site network, PCI is a true market leader in packaging serialization and anti-counterfeiting.

PCI’s pharmaceutical packaging design department provides an innovative and value added service. Our dedicated team of in-house design specialists deliver insightful packaging design and practical knowledge to deliver differentiated and cost-effective packaging solutions.

Our experience in commercial product launch is unparalleled. PCI affords its customers agility in a dynamic commercial market, with the flexibility to adapt quickly to changing market demands.

PCI provides comprehensive pharmaceutical product launch services delivering speed-to-market each and every time

Compliance and Adherence Packaging can play an effective role in maximizing patient compliance and adherence by helping to address core challenges through the use of support tools. PCI provides insightful and multifaceted solutions for addressing patient compliance and adherence for clinical investigational medicines as well as commercial applications.

We have over 50 years’ experience in the pharmaceutical contract packaging sector with significant capabilities and expertise in the commercial packaging of biologics and biosimilars.

PCI offers in-house laboratories providing a range of packaging and analytical laboratory services to support clients in the development, clinical and commercial supply of medicines globally.

Our Packaging QP Services delivers a vital role in bringing new products to market. Our highly experienced team ensures that commercial products are launched in accordance with global regulatory requirements with ongoing batch release for commercially established products.

PCI provides a comprehensive service at each stage of the product lifecycle for a wide range of dosage forms, in full compliance with GMP regulatory standards for both highly potent and non-potent drug products.

With unrivalled experience in packaging and labeling, we combine knowledge, expertise, innovative technologies and a dedicated team of specialists to ensure the highest quality standard of clinical supplies.

Leveraging over 20 years of experience in injectable packaging, PCI supports multiple delivery forms from Phase I through commercialization.

As pharmaceutical companies seek to streamline early phase development to establish proof of concept quickly and efficiently, PCI’s Speed to Study^TM services are designed to manoeuvre complex trial designs with maximized flexibility and speed.

PCI offers over 30 years’ experience in the storage and distribution of clinical trial materials, effectively storing and distributing thousands of patient kits to over 100 countries world-wide.

PCI offers the expertise to assist clients with overcoming hurdles experienced during the clinical lifecycle, with a collaborative approach to solving challenges that may arise.